Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

abacavir-lamiVUDine-zidovudine

abacavir-lamiVUDine-zidovudine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Trizivir TABLET, ORAL 300 mg-150 mg-300 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

abacavir-lamiVUDine-zidovudine (Trizivir)

  • 300 mg-150 mg-300 mg tablet oral BID

abacavir (Ziagen) AND lamiVUDine (Epivir HBV) AND zidovudine (Retrovir)

  • ONE 300 mg abacavir tablet PLUS ONE 150 mg lamiVUDine tablet PLUS ONE 300 mg zidovudine tablet BID

Must weigh at least 40 kg to take drugs.  Patient may use home drug supply.

Trizivir medication guide

Dispense individual components separately.

Reviewed:  July 27, 2005

Last updated: Jun. 29, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved